Literature DB >> 19451236

Approaches to malaria vaccine development using the retrospectroscope.

Vanessa Sardá1, David C Kaslow, Kim C Williamson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19451236      PMCID： PMC2715670          DOI： 10.1128/IAI.00122-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


× No keyword cloud information.
  104 in total

1.  Characterization of promoters and stable transfection by homologous and nonhomologous recombination in Plasmodium falciparum.

Authors:  B S Crabb; A F Cowman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes.

Authors:  K C Williamson; D B Keister; O Muratova; D C Kaslow
Journal:  Mol Biochem Parasitol       Date:  1995-12       Impact factor: 1.759

3.  Indicators of life-threatening malaria in African children.

Authors:  K Marsh; D Forster; C Waruiru; I Mwangi; M Winstanley; V Marsh; C Newton; P Winstanley; P Warn; N Peshu
Journal:  N Engl J Med       Date:  1995-05-25       Impact factor: 91.245

4.  Transformation of Plasmodium falciparum malaria parasites by homologous integration of plasmids that confer resistance to pyrimethamine.

Authors:  Y Wu; L A Kirkman; T E Wellems
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

5.  A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

Authors:  J A Stoute; M Slaoui; D G Heppner; P Momin; K E Kester; P Desmons; B T Wellde; N Garçon; U Krzych; M Marchand
Journal:  N Engl J Med       Date:  1997-01-09       Impact factor: 91.245

6.  Cloning the P. falciparum gene encoding PfEMP1, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes.

Authors:  D I Baruch; B L Pasloske; H B Singh; X Bi; X C Ma; M Feldman; T F Taraschi; R J Howard
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

7.  The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes.

Authors:  X Z Su; V M Heatwole; S P Wertheimer; F Guinet; J A Herrfeldt; D S Peterson; J A Ravetch; T E Wellems
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

8.  A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.

Authors:  M J Blackman; H G Heidrich; S Donachie; J S McBride; A A Holder
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

9.  Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth and invasion in vitro, but act in cooperation with monocytes.

Authors:  H Bouharoun-Tayoun; P Attanath; A Sabchareon; T Chongsuphajaisiddhi; P Druilhe
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  Switches in expression of Plasmodium falciparum var genes correlate with changes in antigenic and cytoadherent phenotypes of infected erythrocytes.

Authors:  J D Smith; C E Chitnis; A G Craig; D J Roberts; D E Hudson-Taylor; D S Peterson; R Pinches; C I Newbold; L H Miller
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582
View more
  2 in total

Review 1.  Antimalarial Drug Resistance: A Threat to Malaria Elimination.

Authors:  Didier Menard; Arjen Dondorp
Journal:  Cold Spring Harb Perspect Med       Date:  2017-07-05       Impact factor: 6.915

2.  Transdermal Immunization of Elastic Liposome-Laden Recombinant Chimeric Fusion Protein of P. falciparum (PfMSP-Fu24) Mounts Protective Immune Response.

Authors:  Ramesh Chaudhari; Nikunj Tandel; Kiran Sahu; Sushmita Negi; Hilal Bashir; Arzu Rupareliya; Ravi Pn Mishra; Sarat K Dalai; Rajeev K Tyagi
Journal:  Nanomaterials (Basel)       Date:  2021-02-05       Impact factor: 5.076
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.